Managing type 2 diabetes effectively requires a combination of medications, lifestyle adjustments, and regular monitoring. GLICLAGLAZE TRIO 40/0.3 containing Gliclazide IP 40 mg, Metformin Hydrochloride IP 500 mg, and Voglibose IP 0.3 mg, offers a potent triple-action approach to controlling blood glucose levels. Designed for patients who require comprehensive management, this combination tablet helps regulate fasting and post-meal blood sugar while supporting overall metabolic health.
Manufactured by Steris Healthcare Pvt. Ltd., a trusted name in the pharmaceutical industry, GLICLAGLAZE TRIO 40/0.3 ensures safety, efficacy, and quality in every dose. This medication is suitable for patients seeking a reliable, scientifically backed solution for type 2 diabetes.
What is GLICLAGLAZE TRIO 40/0.3?
GLICLAGLAZE TRIO 40/0.3 is a combination oral anti-diabetic medication formulated to provide triple-action blood sugar control. It combines:
Gliclazide IP 40 mg: A sulfonylurea that stimulates pancreatic beta cells to release insulin, helping lower blood glucose levels.
Metformin Hydrochloride IP 500 mg: A biguanide that reduces hepatic glucose production and enhances insulin sensitivity in peripheral tissues.
Voglibose IP 0.3 mg: An alpha-glucosidase inhibitor that slows carbohydrate absorption in the intestines, preventing post-meal sugar spikes.
Together, these three agents address multiple aspects of type 2 diabetes, offering comprehensive glycemic management.
Uses of Gliclazide, Metformin, and Voglibose Combination
GLICLAGLAZE TRIO 40/0.3 is primarily used for:
Type 2 Diabetes Management: Helps maintain fasting and postprandial blood sugar levels within the normal range.
Post-Meal Sugar Control: Voglibose minimizes rapid spikes in blood glucose after meals.
Enhanced Insulin Sensitivity: Metformin improves the body’s ability to use insulin effectively.
Support for Pancreatic Function: Gliclazide stimulates insulin release to manage glucose effectively.
Reducing Diabetes Complications: Long-term glycemic control reduces risks of neuropathy, retinopathy, cardiovascular issues, and kidney damage.
By targeting multiple mechanisms, GLICLAGLAZE TRIO 40/0.3 ensures patients maintain balanced blood sugar levels throughout the day.
How GLICLAGLAZE TRIO 40/0.3 Works
The combination works through three complementary mechanisms:
Gliclazide: Stimulates pancreatic beta cells to produce insulin, reducing blood sugar after meals.
Metformin Hydrochloride: Lowers liver glucose production and improves peripheral tissue uptake of glucose, controlling fasting blood sugar.
Voglibose: Delays carbohydrate absorption in the intestines, preventing postprandial hyperglycemia.
This triple-action approach ensures both fasting and post-meal glucose control, making it an ideal therapy for type 2 diabetes.
Dosage and Administration
The dosage of GLICLAGLAZE TRIO 40/0.3 should be individualized based on blood sugar levels and patient response:
Usually taken once daily before meals or as directed by a healthcare provider.
Swallow the tablet whole with water; do not crush or chew.
Blood glucose levels should be monitored regularly to ensure optimal efficacy.
Any dose adjustments should only be made under medical supervision.
Possible Side Effects
While GLICLAGLAZE TRIO 40/0.3 is generally well-tolerated, some patients may experience mild side effects:
Nausea, vomiting, or stomach upset
Diarrhea or abdominal discomfort
Hypoglycemia (low blood sugar), with symptoms such as sweating, shakiness, dizziness, or confusion
Mild headache or fatigue
Serious side effects are uncommon but may include:
Severe hypoglycemia
Allergic reactions (rash, itching, swelling)
Liver or kidney dysfunction
Patients should report any unusual or persistent symptoms to their healthcare provider immediately.
Precautions and Safety Information
Before taking GLICLAGLAZE TRIO 40/0.3, patients should consider the following:
Inform your doctor if you have kidney, liver, or heart conditions.
Monitor blood glucose regularly, especially during illness, dietary changes, or increased physical activity.
Pregnant or breastfeeding women should use this medication only under medical supervision.
Maintain a healthy diet and exercise routine for optimal results.
Avoid alcohol, as it may increase the risk of hypoglycemia.
Why Choose Steris Healthcare Pvt. Ltd.?
Steris Healthcare is a leading pharmaceutical company recognized for quality, innovation, and patient safety. Choosing GLICLAGLAZE TRIO 40/0.3 from Steris Healthcare ensures:
WHO-GMP Certified Manufacturing: Adherence to international quality standards for safety and efficacy.
Clinically Proven Formulation: Effective triple-action therapy for comprehensive blood sugar control.
Patient-Centric Approach: Designed for convenience and improved adherence.
Reliable & Accessible: Available nationwide at competitive pricing with professional support.
Trusted Brand Reputation: Steris Healthcare is known for producing safe, high-quality medications.
Tips for Patients Taking GLICLAGLAZE TRIO 40/0.3
To maximize the benefits of this combination therapy:
Take the medication consistently at the same time every day.
Follow a balanced diet and exercise routine as recommended by your healthcare provider.
Monitor blood glucose frequently and maintain a log for effective tracking.
Avoid skipping meals to prevent hypoglycemia.
Report any side effects or unusual symptoms promptly.
Frequently Asked Questions
1. What is GLICLAGLAZE TRIO 40/0.3 used for?
It is used to manage type 2 diabetes by controlling fasting and post-meal blood sugar levels.
2. Can this tablet cause low blood sugar?
Yes, hypoglycemia may occur, especially if meals are skipped. Symptoms include sweating, shakiness, or confusion.
3. Can it be used long-term?
Yes, under medical supervision, it can be used as a long-term solution for type 2 diabetes management.
4. What should I do if I miss a dose?
Take it as soon as you remember, unless it’s almost time for the next dose. Do not double the dose.
5. Can it be used during pregnancy or breastfeeding?
Only under medical supervision. Always consult your healthcare provider before use.
6. How should I store this medication?
Keep it in a cool, dry place away from sunlight and out of reach of children.
Conclusion
GLICLAGLAZE TRIO 40/0.3 is a triple-action oral anti-diabetic medication combining Gliclazide 40 mg, Metformin Hydrochloride 500 mg, and Voglibose 0.3 mg. It provides effective control of both fasting and post-meal blood sugar levels, addressing multiple aspects of type 2 diabetes.
Manufactured by Steris Healthcare Pvt. Ltd., a WHO-GMP certified and trusted pharmaceutical company, GLICLAGLAZE TRIO 40/0.3 ensures quality, efficacy, and patient convenience. For patients seeking reliable, safe, and clinically proven diabetes management, this combination tablet offers a scientifically backed solution to maintain glycemic control and improve overall quality of life.
📩 For further information, email: info@sterispharma.com / contact@sterispharma.com
📞 Call/WhatsApp: 8209542042, 8824175417
👉
